专家洞见

GLG的专家团拥有约 100 万名成员,涵盖所有主要行业与地区的意见领袖。
在此可浏览部分专家的观点。

Digital Health Platforms Buy and Build
文章

Digital Health Platforms Buy and Build

The State of Pharma Contract Development and Manufacturing Organizations
文章

The State of Pharma Contract Development and Manufacturing Organizations

What We Can Do about Wasted Pharmaceuticals
文章

What We Can Do about Wasted Pharmaceuticals

Challenges and Opportunities in Australia’s Radiology Industry
文章

Challenges and Opportunities in Australia’s Radiology Industry

The Inflation Reduction Act: What Drugmakers Should Know
文章

The Inflation Reduction Act: What Drugmakers Should Know

Looking at the Australian National Disability Insurance Scheme (NDIS)
文章

Looking at the Australian National Disability Insurance Scheme (NDIS)

At-Home Healthcare After COVID-19
文章

At-Home Healthcare After COVID-19

TPP Testing in Pharma: Best Practices
文章

TPP Testing in Pharma: Best Practices

Drilling into Dental Industry Trends
文章

Drilling into Dental Industry Trends

Radiation Oncology Market: The Battle for Doctors
文章

Radiation Oncology Market: The Battle for Doctors

GLG Institute’s “Effective Leadership Development in a Post-COVID World” roundtable highlights
文章

GLG Institute’s “Effective Leadership Development in a Post-COVID World” roundtable highlights

Analyzing Australia’s Response to COVID-19
文章

Analyzing Australia’s Response to COVID-19

Report: Illuminating Invisible Inequities in Healthcare
文章

Report: Illuminating Invisible Inequities in Healthcare

Biogen’s Aduhelm: An Update on the Commercial Rollout
文章

Biogen’s Aduhelm: An Update on the Commercial Rollout

FDA’s Controversial Aduhelm Approval: What Happens Next?
文章

FDA’s Controversial Aduhelm Approval: What Happens Next?

The Future of Healthcare in India
文章

The Future of Healthcare in India

Professor Lawrence Gostin on Mask and Vaccine Mandates
文章

Professor Lawrence Gostin on Mask and Vaccine Mandates

Why the FDA Was Correct in Approving Biogen’s Aducanumab
文章

Why the FDA Was Correct in Approving Biogen’s Aducanumab

Insights from GLG Institute’s 2021 Healthcare Leadership Summit
文章

Insights from GLG Institute’s 2021 Healthcare Leadership Summit

Jeb Bush and Martin O’Malley on Reopening After COVID-19
文章

Jeb Bush and Martin O’Malley on Reopening After COVID-19

COVID Vaccinations in Hong Kong: An Update
文章

COVID Vaccinations in Hong Kong: An Update

COVID Vaccinations in Hong Kong: Q and A
文章

COVID Vaccinations in Hong Kong: Q and A

Biden’s Healthcare Priorities
文章

Biden’s Healthcare Priorities

Updates on COVID-19: New Variants and Vaccination Campaigns
文章

Updates on COVID-19: New Variants and Vaccination Campaigns

An Overview of Southeast Asian Healthcare Delivery
文章

An Overview of Southeast Asian Healthcare Delivery

Obamacare Likely to Be Safe from Supreme Court, Kathleen Sebelius Says
文章

Obamacare Likely to Be Safe from Supreme Court, Kathleen Sebelius Says

Kathleen Sebelius: ‘Trickle-Down Chaos’ Led to Poor COVID Response
文章

Kathleen Sebelius: ‘Trickle-Down Chaos’ Led to Poor COVID Response

The Future of Digital Health in India
文章

The Future of Digital Health in India

Healthcare Leadership: 3 Takeaways from 2020
文章

Healthcare Leadership: 3 Takeaways from 2020

Covid-19 Vaccines and Therapeutics: Where We Stand Now
文章

Covid-19 Vaccines and Therapeutics: Where We Stand Now

Is Asian Healthcare on the Verge of a Digital Revolution?
文章

Is Asian Healthcare on the Verge of a Digital Revolution?

J.P. Morgan Healthcare 2021: How to Make the Most of This Year’s Virtual Conference
文章

J.P. Morgan Healthcare 2021: How to Make the Most of This Year’s Virtual Conference

The 2021 Physician Staffing Outlook
文章

The 2021 Physician Staffing Outlook

The Nutraceuticals Market Is Booming. Will It Last?
文章

The Nutraceuticals Market Is Booming. Will It Last?

Ebook: The Rise of Telemedicine: Survey and Perspectives
文章

Ebook: The Rise of Telemedicine: Survey and Perspectives

The Future of the ACA in a Post-Ginsburg World
文章

The Future of the ACA in a Post-Ginsburg World

COVID-19 Vaccine Update: The Global Connection and Public Health Issues
文章

COVID-19 Vaccine Update: The Global Connection and Public Health Issues

COVID-19 Update: The Race for a Vaccine   
文章

COVID-19 Update: The Race for a Vaccine  

Is the Fertility Solutions Space Due for a Recovery Soon?
文章

Is the Fertility Solutions Space Due for a Recovery Soon?

Huge Growth Potential in Femtech and Maternal Services
文章

Huge Growth Potential in Femtech and Maternal Services

Telemedicine Survey: Patient and Physician Adoption
文章

Telemedicine Survey: Patient and Physician Adoption

Women Want Menopause Solutions. Will Companies Meet the Need?
文章

Women Want Menopause Solutions. Will Companies Meet the Need?

Telemedicine Dynamics: Regulatory Perspective
文章

Telemedicine Dynamics: Regulatory Perspective

What Does K-12 School Reopening Look Like for Students?
文章

What Does K-12 School Reopening Look Like for Students?

Telemedicine Dynamics: Payer Perspective
文章

Telemedicine Dynamics: Payer Perspective

COVID-19 Vaccines: Moderna, Pfizer/BioNTech, AstraZeneca/Oxford
文章

COVID-19 Vaccines: Moderna, Pfizer/BioNTech, AstraZeneca/Oxford

A Look at Moderna’s SARS-CoV-2 Vaccine
文章

A Look at Moderna’s SARS-CoV-2 Vaccine

The Cast Is Coming Off for the Orthopedics Field to Make a Full Recovery
文章

The Cast Is Coming Off for the Orthopedics Field to Make a Full Recovery

Dermatology’s COVID-19 Problems Are Deep and Will Take Time to Heal
文章

Dermatology’s COVID-19 Problems Are Deep and Will Take Time to Heal

COVID-19 May Have Blurred the Ophthalmology Sector, but Recovery Is a Few Blinks Away
文章

COVID-19 May Have Blurred the Ophthalmology Sector, but Recovery Is a Few Blinks Away

COVID-19 and Public Perception
文章

COVID-19 and Public Perception

A Quick Take on STAT’s Remdesivir April 16 Reporting
文章

A Quick Take on STAT’s Remdesivir April 16 Reporting

How Prepared Are Hospitals for the Surge of COVID-19 Patients?
文章

How Prepared Are Hospitals for the Surge of COVID-19 Patients?

Shelter-in-Place May Not Be Enough to Fight COVID-19, Says Former CDC Doctor
文章

Shelter-in-Place May Not Be Enough to Fight COVID-19, Says Former CDC Doctor

Where We Are in the Global Response to COVID-19
文章

Where We Are in the Global Response to COVID-19

COVID-19: A Former City Health Commissioner’s Perspective
文章

COVID-19: A Former City Health Commissioner’s Perspective

What Will It Take to Develop a Vaccine for the Virus that Causes COVID-19?
文章

What Will It Take to Develop a Vaccine for the Virus that Causes COVID-19?

How Will COVID-19 Affect the Business of U.S. Hospitals?
文章

How Will COVID-19 Affect the Business of U.S. Hospitals?

COVID-19: What We Know So Far February 25
文章

COVID-19: What We Know So Far February 25

Assessing the COVID-19 Outbreak Jan 31
文章

Assessing the COVID-19 Outbreak Jan 31

订阅 GLG 洞见趋势月度专栏

输入您的电子邮件,接收我们的月度通讯,获取来自全球约 100 万名 GLG 专家团成员的专业洞见。